Pooled analysis reveals semaglutide shows good efficacy in older adults aged over 65 years
A new analysis of the STEP trials carried out by semaglutide manufacturer Novo Nordisk has analyzed various trials to show the safety and efficacy of the obesity drug semaglutide in older adults (over 65 years), and found ...
May 10, 2026
0
3









